𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate

✍ Scribed by K. Subramaniam; S. Chitturi; M. Brown; P. Pavli


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
188 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Lamivudine resistance and exacerbation o
✍ Maria Esteve; Carme Loras; Ferran GonzΓ‘lez-Huix πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 1 views

2004 we reported 3 cases of chronic hepatitis B in Crohn's disease (CD) patients from a cohort of 80 patients treated with infliximab. 1 Two patients showed severe reactivation, 1 of whom died. Based on the American Association for the Study of Liver Disease (AASLD) and European guidelines, 2,3 pree

Guttate psoriasis induced by infliximab
✍ Marta Costa-Romero; Pablo Coto-Segura; Sonsoles Suarez-Saavedra; Eduardo Ramos-P πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

strong clinical significance for the cause and the mechanism of Crohn's disease. More and more evidence has suggested that gut bacteria play a critical role in the development of inflammatory bowel disease, and Crohn's disease seems to develop in the intestine largely as a result of aberrant interac

Splenic function and IgM-memory B cells
✍ Antonio Di Sabatino; M. Manuela Rosado; Paolo Cazzola; Paolo Biancheri; Francesc πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 308 KB πŸ‘ 2 views

Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-␣ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat